Shenzhen Readline Biotech Co., Ltd. is an innovative bio-pharmaceutical high-tech enterprise with enzyme catalysis technology as its core (This technology has won the 2018 Nobel Prize in Chemistry) and multidisciplinary application. Readline Biotech is the first company to apply the directed evolution of enzymes to the all-green large-scale production of API such as peptides, carbohydrate and nucleic acids in the world. These API are mainly used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers and other fields.